LU68476A1 - - Google Patents

Info

Publication number
LU68476A1
LU68476A1 LU68476A LU68476DA LU68476A1 LU 68476 A1 LU68476 A1 LU 68476A1 LU 68476 A LU68476 A LU 68476A LU 68476D A LU68476D A LU 68476DA LU 68476 A1 LU68476 A1 LU 68476A1
Authority
LU
Luxembourg
Application number
LU68476A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU68476A1 publication Critical patent/LU68476A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU68476A 1972-09-26 1973-09-24 LU68476A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722247187 DE2247187A1 (de) 1972-09-26 1972-09-26 Imidazolylessigsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
LU68476A1 true LU68476A1 (en:Method) 1973-12-07

Family

ID=5857425

Family Applications (1)

Application Number Title Priority Date Filing Date
LU68476A LU68476A1 (en:Method) 1972-09-26 1973-09-24

Country Status (13)

Country Link
US (1) US3950354A (en:Method)
JP (2) JPS584023B2 (en:Method)
AT (1) AT324326B (en:Method)
BE (1) BE805210A (en:Method)
CA (1) CA979898A (en:Method)
CH (2) CH593944A5 (en:Method)
DE (1) DE2247187A1 (en:Method)
FR (1) FR2200013B1 (en:Method)
GB (1) GB1402693A (en:Method)
IL (1) IL43298A (en:Method)
LU (1) LU68476A1 (en:Method)
NL (1) NL7313272A (en:Method)
PL (2) PL91055B1 (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
ES2329356T3 (es) * 2002-06-12 2009-11-25 Chemocentryx, Inc. Derivados de piperazina 1-arilo-4-sustituidos utilizados como antagonistas de ccr1 para el tratamiento de enfermedades inflamatorias e inmunitarias.
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU60908A1 (en:Method) * 1969-05-21 1970-07-16

Also Published As

Publication number Publication date
JPS4969811A (en:Method) 1974-07-05
GB1402693A (en) 1975-08-13
US3950354A (en) 1976-04-13
BE805210A (fr) 1974-03-25
FR2200013B1 (en:Method) 1977-09-09
DE2247187A1 (de) 1974-03-28
AT324326B (de) 1975-08-25
IL43298A0 (en) 1973-11-28
CA979898A (en) 1975-12-16
CH593944A5 (en:Method) 1977-12-30
IL43298A (en) 1977-02-28
PL95785B1 (pl) 1977-11-30
CH599194A5 (en:Method) 1978-05-12
NL7313272A (en:Method) 1974-03-28
FR2200013A1 (en:Method) 1974-04-19
JPS584023B2 (ja) 1983-01-24
PL91055B1 (en:Method) 1977-02-28
JPS4969668A (en:Method) 1974-07-05

Similar Documents

Publication Publication Date Title
FR2257627A2 (en:Method)
FR2200013B1 (en:Method)
JPS5746021B2 (en:Method)
FR2201052B1 (en:Method)
JPS4934989U (en:Method)
JPS4971587A (en:Method)
JPS4979320U (en:Method)
JPS5126399Y2 (en:Method)
JPS5035839Y2 (en:Method)
JPS5124065Y2 (en:Method)
JPS5215397Y2 (en:Method)
JPS523270Y2 (en:Method)
JPS5439592B2 (en:Method)
JPS4911097U (en:Method)
JPS4972003U (en:Method)
JPS4973326U (en:Method)
JPS4973443A (en:Method)
JPS4893570U (en:Method)
AU62009S (en:Method)
CH565687A5 (en:Method)
CH565103A5 (en:Method)
CH567136A5 (en:Method)
CH1200372A4 (en:Method)
CH566315A5 (en:Method)
CH568230A5 (en:Method)